How have HBP shares performed in 2024?

Helix BioPharma's stock was trading at C$0.21 at the start of the year. Since then, HBP stock has decreased by 14.3% and is now trading at C$0.18. View the best growth stocks for 2024 here .

When is Helix BioPharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024. View our HBP earnings forecast .

What other stocks do shareholders of Helix BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma investors own include Lakeland Industries (LAKE) , Liquidia (LQDA) , Ovintiv (OVV) , SIG (SHI) , Green Organic Dutchman (TGOD) , Zynerba Pharmaceuticals (ZYNE) , American Airlines Group (AAL) , Aurora Cannabis (ACB) , Apollo Investment (AINV) and Aphria (APHA) .

How do I buy shares of Helix BioPharma?

Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:HBP

Helix BioPharma (HBP) Stock Price, News & Analysis

→ Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad)

Free HBP Stock Alerts

C$0.18

-0.02 (-10.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: C$0.18
▼
C$0.18
50-Day Range: C$0.17
▼
C$0.21
52-Week Range: C$0.15
▼
C$0.26

Volume: 5,100 shs
Average Volume: 15,673 shs
Market Capitalization: C$41.30 million

P/E Ratio: N/A
Dividend Yield: 1.50%
Price Target: N/A

Stock Analysis Chart Competitors Earnings

Get Helix BioPharma alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About Helix BioPharma Stock (TSE:HBP)

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

HBP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HBP Stock News Headlines

March 28, 2024 | ca.finance.yahoo.com

Canadian Investment Regulatory Organization Trading Halt - HBP

October 10, 2023 | finance.yahoo.com

Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

April 19, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

August 22, 2023 | stockhouse.com

Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes

June 14, 2023 | msn.com

Helix Biopharma GAAP EPS of -C$0.01

June 14, 2023 | finance.yahoo.com

Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results

November 1, 2022 | proactiveinvestors.com

Helix BioPharma advances clinical development of lead candidate L-DOS47, but manages to decrease R&D expenses in 2022 fiscal year

November 1, 2022 | finance.yahoo.com

HELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End Results

April 19, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

September 2, 2022 | proactiveinvestors.com

Helix BioPharma Corp names Dr Gabrielle Siegers as its head of research and development

September 2, 2022 | proactiveinvestors.com

Helix BioPharma names Dr Gabrielle Siegers as head of research and development

September 1, 2022 | finance.yahoo.com

Helix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & Development

August 30, 2022 | finance.yahoo.com

Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP

June 14, 2022 | finance.yahoo.com

HELIX BIOPHARMA Corp. Announces Fiscal 2022 Third Quarter Results

June 3, 2022 | finance.yahoo.com

Helix Biopharma Corp. Announces Closure of Early Warrant Exercise Incentive Program | Raises Aggregate $3.21 Million

May 17, 2022 | finance.yahoo.com

Insiders may be rethinking their CA$3.0m Helix BioPharma Corp. (TSE:HBP) investment now that the company has lost CA$5.0m in value

April 22, 2022 | finance.yahoo.com

Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.

April 18, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

April 18, 2022 | finance.yahoo.com

Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

April 7, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Announces Board Resignation

March 22, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Management and Board Changes

March 22, 2022 | finance.yahoo.com

Helix Biopharma Corp. Announces Management and Board Changes

March 16, 2022 | finanznachrichten.de

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results

March 16, 2022 | proactiveinvestors.com

Helix BioPharma announces sudden passing of interim CEO Slawomir Majewski

March 11, 2022 | apnews.com

Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

March 11, 2022 | finance.yahoo.com

Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

March 11, 2022 | finance.yahoo.com

CORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

See More Headlines

Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/18/2024
Next Earnings (Estimated): 4/24/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: TSE:HBP
CUSIP: N/A
CIK: N/A
Web: www.helixbiopharma.com
Phone: +1-416-9253232
Fax: N/A
Employees: 9
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.03)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-5,940,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -111.88%

Debt

Debt-to-Equity Ratio: 773.67
Current Ratio: 1.46
Quick Ratio: 1.04

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 229,440,000
Free Float: N/A
Market Cap: C$41.30 million
Optionable: Not Optionable
Beta: -0.74

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Jacek Antas
Chairman & CEO
Mr. Praveen Kumar Varshney F.C.A. (Age 58)
FCA, FCPA, LLB, CFO & Corporate Secretary
Dr. Gabrielle M. Siegers M.A.
Ph.D., Head of R&D
Dr. Srikanth Sola
Chief Strategy Officer
Dr. Christof Boehler
Chief Business Development Officer

Key Competitors

View All Competitors

HBP Stock Analysis - Frequently Asked Questions

How have HBP shares performed in 2024?: Helix BioPharma's stock was trading at C$0.21 at the start of the year. Since then, HBP stock has decreased by 14.3% and is now trading at C$0.18.
View the best growth stocks for 2024 here.
When is Helix BioPharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our HBP earnings forecast.
What other stocks do shareholders of Helix BioPharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma investors own include Lakeland Industries (LAKE), Liquidia (LQDA), Ovintiv (OVV), SIG (SHI), Green Organic Dutchman (TGOD), Zynerba Pharmaceuticals (ZYNE), American Airlines Group (AAL), Aurora Cannabis (ACB), Apollo Investment (AINV) and Aphria (APHA).
How do I buy shares of Helix BioPharma?: Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:HBP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial